MolMed SpA
Records under this name other than the patents MolMed SpA holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,642,311 | Thymidine kinase Term ended Term ended Jun 17, 2025 · From the USPTO record | Term ended | Term ended Jun 17, 2025 | From the USPTO record |
| US 8,357,788 | Thymidine kinase Lapsed on the fee record Ended Jan 22, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 22, 2025 | From the USPTO record |
| US 9,441,245 | Stable production of lentiviral vectors Lapsed on the fee record Ended Sep 13, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 13, 2024 | From the USPTO record |
| US 9,068,016 | Conjugates for the treatment of mesothelioma Lapsed on the fee record Ended Jun 30, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 30, 2023 | From the USPTO record |
| US 10,314,925 | Thymidine kinase Lapsed on the fee record Ended Jun 11, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 11, 2023 | From the USPTO record |
| US 9,005,945 | Thymidine kinase Lapsed on the fee record Ended Apr 14, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 14, 2023 | From the USPTO record |
| US 10,155,052 | Thymidine kinase Lapsed on the fee record Ended Dec 18, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 18, 2022 | From the USPTO record |
| US 10,144,937 | Stable production of lentiviral vectors Lapsed on the fee record Ended Dec 4, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 4, 2022 | From the USPTO record |
| US 7,795,386 | Peptides comprising an isoDGR motif Formerly held Lapsed on the fee record Ended Sep 14, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 14, 2022 | From the USPTO record |
| US 9,782,496 | Immunoconjugates for the treatment of tumours Lapsed on the fee record Ended Oct 10, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 10, 2021 | From the USPTO record |